METRIC phase III study: Efficacy of trametinib (T), a potent and selective MEK inhibitor (MEKi), in progression-free survival (PFS) and overall survival (OS), compared with chemotherapy (C) in patients (pts) with BRAFV600E/K mutant advanced or metastatic melanoma (MM).
Caroline Robert
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Keith T. Flaherty
Consultant or Advisory Role - GlaxoSmithKline
Peter Hersey
No relevant relationships to disclose
Paul D. Nathan
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Claus Garbe
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Genta; GlaxoSmithKline; MSD; Philogen; Roche; Swedish Orphan SOBI
Honoraria - Bristol-Myers Squibb; MSD; Philogen; Roche; Swedish Orphan SOBI
Research Funding - Bristol-Myers Squibb; Genta; MSD; Roche; SOBI
Mohammed M. Milhem
No relevant relationships to disclose
Lev V. Demidov
Honoraria - GlaxoSmithKline; MSD
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer; Roche
Jessica C. Hassel
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Piotr Rutkowski
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis
Honoraria - Bristol-Myers Squibb (B); GlaxoSmithKline; MSD; Novartis; Pfizer
Peter Mohr
No relevant relationships to disclose
Reinhard Dummer
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Uwe Trefzer
Consultant or Advisory Role - GlaxoSmithKline
James M. G. Larkin
Consultant or Advisory Role - GlaxoSmithKline
Jochen Utikal
Honoraria - GlaxoSmithKline
Michelle Casey
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Laurie Jill Sherman
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Wendy A. Crist
Employment or Leadership Position - GlaxoSmithKline
Frank S. Wu
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Kiran Patel
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Dirk Schadendorf
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline